Elderly males with non-neurogenic urinary incontinence can successfully manage their condition with AUS implantation.

Published Date: 26 May 2023

"Efficacy, Safety, and Reoperation-free Survival of Artificial Urinary Sphincter in," a study published in European Urology Open Science, claims.

Read Full News

Latest News

Vasectomy Reversal More Cost-Effective Than IVF

Most couples younger than 40 years can achieve pregnancy within typical $30,000-$40,000 employer fertility benefits with reversal, new research indicates.

US Judge Rejects Bayer Bid to Block Johnson & Johnson Prostate Cancer Drug Claims

A U.S. judge has rejected Bayer's request for an injunction to block Johnson & Johnson's alleged false advertising that ⁠its multibillion-dollar drug cuts the risk of...

This Test Could Predict Incontinence Risk After HoLEP

Men with a shorter membranous urethra appear more likely to experience urinary incontinence after laser enucleation for benign prostatic hyperplasia, a new study shows.

Smartphone App Helps Delay Ejaculation

The app improves sexual control and doubles ejaculation latency time in a randomized trial.

US FDA Approves Lantheus' New Prostate Cancer Imaging Formulation

The U.S. Food and Drug Administration on Friday approved a new formulation of Lantheus Holdings' prostate ⁠cancer imaging agent, aimed at improving scanning access through...

Will a Smart Toilet Turn the Home Into a Diagnostic Center?

Smart toilets show promise for passive monitoring of stool and urine to detect potential health issues, but challenges remain.

Todays Updates

Italy's Arbovirus Threat: Is Europe at Greater Risk?

Experts say arboviral outbreaks are becoming a growing public health concern in Europe because of expanding mosquito activity and climate shifts.

Todays Updates

Italy's Arbovirus Threat: Is Europe at Greater Risk?

Experts say arboviral outbreaks are becoming a growing public health concern in Europe because of expanding mosquito activity and climate shifts.

Latest News

Most couples younger than 40 years can achieve pregnancy within typical $30,000-$40,000 employer fertility benefits with reversal, new research indicates.

A U.S. judge has rejected Bayer's request for an injunction to block Johnson & Johnson's alleged false advertising that ⁠its multibillion-dollar drug cuts the risk of...

Men with a shorter membranous urethra appear more likely to experience urinary incontinence after laser enucleation for benign prostatic hyperplasia, a new study shows.

The app improves sexual control and doubles ejaculation latency time in a randomized trial.

The U.S. Food and Drug Administration on Friday approved a new formulation of Lantheus Holdings' prostate ⁠cancer imaging agent, aimed at improving scanning access through...

Smart toilets show promise for passive monitoring of stool and urine to detect potential health issues, but challenges remain.

News All Time

During the Accountable Care Meeting, CMS Officials were pressed on the topic of scanner fraud.

"We would appreciate it if you could give the matter more immediate attention," one ACO member said.

Nivolumab Plus Chemotherapy in First Line Approved for Bladder Cancer.

Combination decreased death risk by 22%.

King Charles III's Operation; COVID-19 Timeline Under Question; FDA Approvals Reach Record High.

The staff of MedPage Today has compiled health news and commentary from around the web.

Noninvasive Treatment Effective in Bladder Cancer That Is Not Muscle-Invasive.

An investigational intrusive solution produced a 79% complete response rate.

For Prostate Cancer at Intermediate Risk, SBRT Is Not Less Effective Than Conventional RT.

Similar results are obtained from treatment lasting one to two weeks as compared to therapy lasting up to seven and a half weeks.

The new first-line standard for advanced bladder cancer was produced by a landmark trial.

When compared to chemotherapy, enfortumab vedotin-pembrolizumab doubles OS and PFS.

Should Patients With Advanced Prostate Cancer Get Off the Active Surveillance Train?

Clearly defined rules are needed.

Even in those with HIV, a single dose of antibiotics was able to cure early syphilis.

In a randomized trial, one dosage showed no worse results than a triple-dose regimen.

Removing Cancer Survivors From Oncologic Treatment.

A new approach to care is required.

Cabazitaxel Lower-Dose Schedule Is Viable for Elderly Patients With mCRPC.

Neutropenia of grade three or above, with a twelve-fold reduction in neutropenic consequences.

AR-Pathway Inhibitor Switch for mCRPC is Superseded by Radionuclide Therapy.

With 177Lu-PSMA-617, the time to radiographic progression was doubled.

An RCT Supports HIF-2a Inhibition in Advanced RCC.

Belzutifan outperforms everolimus in the event of immunotherapy-TKI failure.

Finding New Routes to Improve Renal Cell Carcinoma Outcomes.

It is necessary to intervene at several stages of the cancer immunity cycle in order to build on recent successes.

CAR T-Cell Therapy for Renal Cell Carcinoma: "We're Not There Yet".

Possibility of standard of care following current therapies, but significant barriers still need to be overcome.

In severe cases of renal cell carcinoma, tyrosine kinase inhibitor activity is present.

Reactions to the "special medication" zanzalintinib in patients exposed and not exposed to cabozantinib.

Dietary inflammation is associated with the development of urologic cancers.

In health research, the relationship between dietary habits and cancer risks is still a major focus. The has been the subject of a recent meta-analysis.

Early detection of breast cancer may be possible with AI-based mammography microcalcification detection and classification.

Achieves a High Disease Control Rate in Head and Neck BCC with Vismodegib-RT Regimen.

Participate and win cash vouchers

Get updates on the latest events happening around the world

2.

Higher Binge Drinking Rates Linked to New Cannabis Laws.

3.

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

4.

Ketamine plus psychotherapy for "excellent" PTSD

5.

No Seed Oil-Colon Cancer Link; Avoiding Prostate Biopsy; Top Cancer Advances

1.

Revolutionizing Oncology: Pharmacometric Models in Personalized Cancer Drug Development

2.

HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment

3.

Advancing Cancer Trials: Integrating Master Protocols and Immunotherapy Guidelines

4.

Navigating the Stages of Thyroid Cancer: A Guide for Patients

5.

Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A New Era in Managing Cancer-Associated Thrombosis

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI

3.

Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment

4.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

5.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Elderly males with non-neurogenic urinary incontinence can successfully manage their condition with AUS implantation.

Latest News

Vasectomy Reversal More Cost-Effective Than IVF

US Judge Rejects Bayer Bid to Block Johnson & Johnson Prostate Cancer Drug Claims

This Test Could Predict Incontinence Risk After HoLEP

Smartphone App Helps Delay Ejaculation

US FDA Approves Lantheus' New Prostate Cancer Imaging Formulation

Will a Smart Toilet Turn the Home Into a Diagnostic Center?

Todays Updates

Italy's Arbovirus Threat: Is Europe at Greater Risk?

Todays Updates

Italy's Arbovirus Threat: Is Europe at Greater Risk?

Latest News

News All Time

During the Accountable Care Meeting, CMS Officials were pressed on the topic of scanner fraud.

Nivolumab Plus Chemotherapy in First Line Approved for Bladder Cancer.

King Charles III's Operation; COVID-19 Timeline Under Question; FDA Approvals Reach Record High.

Noninvasive Treatment Effective in Bladder Cancer That Is Not Muscle-Invasive.

For Prostate Cancer at Intermediate Risk, SBRT Is Not Less Effective Than Conventional RT.

The new first-line standard for advanced bladder cancer was produced by a landmark trial.

Should Patients With Advanced Prostate Cancer Get Off the Active Surveillance Train?

Even in those with HIV, a single dose of antibiotics was able to cure early syphilis.

Removing Cancer Survivors From Oncologic Treatment.

Cabazitaxel Lower-Dose Schedule Is Viable for Elderly Patients With mCRPC.

AR-Pathway Inhibitor Switch for mCRPC is Superseded by Radionuclide Therapy.

An RCT Supports HIF-2a Inhibition in Advanced RCC.

Finding New Routes to Improve Renal Cell Carcinoma Outcomes.

CAR T-Cell Therapy for Renal Cell Carcinoma: "We're Not There Yet".

In severe cases of renal cell carcinoma, tyrosine kinase inhibitor activity is present.

Dietary inflammation is associated with the development of urologic cancers.

Recommended News For You

Is Chemotherapy via Peripheral IV Access More Effective Than Central Lines for Testicular Cancer?

Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis

More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer

Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients

Mortality up for children with leukemia from lowest SES neighborhoods

Early detection of breast cancer may be possible with AI-based mammography microcalcification detection and classification.

Achieves a High Disease Control Rate in Head and Neck BCC with Vismodegib-RT Regimen.

Recommended Articles For You

Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond

Seeing the Unseen: The Benefits of Early Stage Breast Cancer Ultrasound

Immuno-Oncology in Daily Practice: Transforming Cancer Care One Patient at a Time

Obesity as a major risk factor for cancer

Whats more on Hidoc Dr.

Medical Updates

KOL Videos

Surveys

Events

Featured News

Featured Articles

Featured Events

Featured KOL Videos

Quick Links

Verification

Welcome to Hidoc Dr.